Cargando…
Genomic characterization of functional high-risk multiple myeloma patients
Multiple myeloma (MM) patients with suboptimal response to induction therapy or early relapse, classified as the functional high-risk (FHR) patients, have been shown to have poor outcomes. We evaluated newly-diagnosed MM patients in the CoMMpass dataset and divided them into three groups: genomic hi...
Autores principales: | Soekojo, Cinnie Yentia, Chung, Tae-Hoon, Furqan, Muhammad Shaheryar, Chng, Wee Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803925/ https://www.ncbi.nlm.nih.gov/pubmed/35102139 http://dx.doi.org/10.1038/s41408-021-00576-3 |
Ejemplares similares
-
Immunotherapy in Multiple Myeloma
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2020) -
Potential Clinical Application of Genomics in Multiple Myeloma
por: Soekojo, Cinnie Yentia, et al.
Publicado: (2018) -
Natural History and Prognostic Factors at First Relapse in Multiple Myeloma
por: Wang, Chen, et al.
Publicado: (2020) -
Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges
por: Da, Yi, et al.
Publicado: (2022) -
Immunoglobulin M Monoclonal Gammopathies of Clinical Significance
por: Girard, Louis-Pierre, et al.
Publicado: (2022)